Shengnan Sun

639 total citations
26 papers, 464 citations indexed

About

Shengnan Sun is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shengnan Sun has authored 26 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Shengnan Sun's work include Antimicrobial Peptides and Activities (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Aquaculture disease management and microbiota (4 papers). Shengnan Sun is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Aquaculture disease management and microbiota (4 papers). Shengnan Sun collaborates with scholars based in China, United States and Belgium. Shengnan Sun's co-authors include Zhen‐Chuan Fan, Guanghui Zhang, Dongsheng Yuan, M. H. Jiang, Demei Meng, Dong Xu, Shiyi Guo, Fanqing Meng, M.K. Lü and Zhe Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Shengnan Sun

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengnan Sun China 12 142 118 107 73 65 26 464
Benjamin Scott Canada 12 48 0.3× 281 2.4× 98 0.9× 88 1.2× 23 0.4× 21 578
Arezoo Shahrivarkevishahi United States 9 25 0.2× 153 1.3× 102 1.0× 95 1.3× 42 0.6× 14 395
Huaifeng Mi China 15 40 0.3× 496 4.2× 50 0.5× 42 0.6× 106 1.6× 45 794
Fanguo Meng China 15 147 1.0× 387 3.3× 165 1.5× 7 0.1× 38 0.6× 35 700
Lorena Vázquez‐Iglesias Spain 14 97 0.7× 205 1.7× 66 0.6× 15 0.2× 42 0.6× 24 469
Andrew C. Brooks United Kingdom 14 157 1.1× 107 0.9× 53 0.5× 24 0.3× 90 1.4× 28 528
Sandra C. Mwakwari United States 11 95 0.7× 323 2.7× 98 0.9× 12 0.2× 56 0.9× 14 592
Tuhin Bhowmick India 11 76 0.5× 233 2.0× 123 1.1× 124 1.7× 10 0.2× 21 606
Erin L. Dodd Canada 10 13 0.1× 159 1.3× 78 0.7× 38 0.5× 23 0.4× 18 372

Countries citing papers authored by Shengnan Sun

Since Specialization
Citations

This map shows the geographic impact of Shengnan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Sun more than expected).

Fields of papers citing papers by Shengnan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Sun. The network helps show where Shengnan Sun may publish in the future.

Co-authorship network of co-authors of Shengnan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Sun. A scholar is included among the top collaborators of Shengnan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Sun. Shengnan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shengnan, et al.. (2025). Regulating the crystal structure of ZnMn2O4 material by Zr doping for rechargeable aqueous zinc-ion batteries. Electrochimica Acta. 520. 145900–145900. 1 indexed citations
2.
Sun, Shengnan, Min Liu, Han Liu, et al.. (2025). Study on the construction of a Chinese cardiovascular physician competency model. Scientific Reports. 15(1). 24327–24327.
3.
Zhao, Shuai, et al.. (2025). A pan-cancer analysis of the prognostic and immunological roles of zinc finger protein 514 in human tumors. Frontiers in Oncology. 15. 1592989–1592989.
4.
Ma, Jianli, Shengnan Sun, Xiaowen Tang, et al.. (2025). Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer. British Journal of Cancer. 134(4). 685–696.
5.
Sun, Shengnan, Aipo Diao, & Zhen‐Chuan Fan. (2024). Green algae-produced multimer cathelicidin-RC1 disrupts membrane integrity for inhibiting bacterial growth. Process Biochemistry. 146. 1–12.
7.
Chen, Yu, Shengnan Sun, Xiaohong Chen, et al.. (2024). Predesign of Covalent‐Organic Frameworks for Efficient Photocatalytic Dehydrogenative Cross‐Coupling Reaction. Advanced Materials. 37(6). e2413638–e2413638. 16 indexed citations
8.
9.
Yang, Zheng, et al.. (2023). Sodium selenite increases drought tolerance by promoting jasmonic acid biosynthesis in cucumber. SHILAP Revista de lepidopterología. 1(1). 14 indexed citations
10.
Sun, Shengnan, et al.. (2023). Chlamydomonas reinhardtii-derived triple BmKbpp distorts membrane integrity for inhibiting bacterial growth. Process Biochemistry. 137. 10–19. 5 indexed citations
11.
Sun, Shengnan, Wolfgang B. Gaertner, & Margaret Reynolds. (2023). Outcomes of Watch and Wait Following Total Neoadjuvant Therapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e340–e340.
12.
Wu, Lei, Shengnan Sun, Meili Sun, et al.. (2022). CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer. Cancer Immunology Immunotherapy. 72(6). 1479–1492. 23 indexed citations
13.
Wu, Lei, Shengnan Sun, Xiuxiu Liu, et al.. (2022). ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis. Frontiers in Immunology. 13. 829640–829640. 7 indexed citations
14.
15.
Meng, Demei, et al.. (2021). Application of antimicrobial peptide mytichitin-CB in pork preservation during cold storage. Food Control. 125. 108041–108041. 45 indexed citations
16.
Lu, Ligong, Meixiao Zhan, Hui Zhang, et al.. (2020). Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies. Hepatology. 73(2). 821–832. 34 indexed citations
17.
Yang, Chun, Shengnan Sun, Qí Zhāng, et al.. (2020). Exosomes of Antler Mesenchymal Stem Cells Improve Postoperative Cognitive Dysfunction in Cardiopulmonary Bypass Rats through Inhibiting the TLR2/TLR4 Signaling Pathway. Stem Cells International. 2020. 1–13. 27 indexed citations
18.
Yang, Min, Ying Liu, Min Wang, et al.. (2019). Biomineralized Gd/Dy composite nanoparticles for enhanced tumor photoablation with precise T/T-MR/CT/thermal imaging guidance. Chemical Engineering Journal. 391. 123562–123562. 6 indexed citations
19.
Guo, Ruixian, Liqiu Mo, Xinxue Liao, et al.. (2008). NUCLEAR FACTOR‐κB MEDIATES CYTOPROTECTION OF HYDROGEN PEROXIDE PRECONDITIONING AGAINST APOPTOSIS INDUCED BY OXIDATIVE STRESS IN PC12 CELLS. Clinical and Experimental Pharmacology and Physiology. 36(3). 304–311. 10 indexed citations
20.
Guo, Shiyi, Dong Xu, Ping Yang, et al.. (2001). A Novel Nonlinear Optical Complex Crystal with an Organic Ligand Coordinated through an O Atom: Tetrathiocyanatocadmiummercury-Dimethyl Sulfoxide. Crystal Research and Technology. 36(6). 609–614. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026